• Tipo News
    RICERCA PARTNER
  • Fonte
    SIMPLER
  • Del

A UK university has discovered a class of natural compounds able to target transient receptor potential channels (TRPC) which are therapeutic targets for several disorders. The project aims to further examine the efficacy of these natural compounds using disease models, pharmacokinetics, and healthy volunteers. Academic partners (particularly with in vivo disease models) and pharmaceutical companies are sought to join the consortium for this Horizon 2020 project proposal.

  • Type and Role of Partner Sought:
    • Academic partner to further assess the in vivo cardiovascular effects using animal models including hypertension models and atherosclerosis;
    • Clinical research partners for research on healthy volunteers including dosage, pharmacokinetics and safety;
    • Industrial partner to manufacture the drug for clinical trial and licensing;
    • Consultancy on drug development service is also needed.

 

Per ulteriori informazioni finalizzate ad attivare una partnership, segnaliamo che è possibile:

  • scrivere all'indirizzo e-mail [email protected],  se localizzati nella regione Emilia-Romagna
  • individuare l'ente di riferimento per la propria regione sul sito ufficiale di Enterprise Europe Network, se localizzati in altre regioni d'Italia riportando, in ogni caso, il codice: RDUK20151028001
Scadenze
Termine di validità della ricerca partner
Data chiusura
Identificativo
RDUK20151028001
Area
Unione europea